Atricure Inc. buy UBS Group AG
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€51.01
Performance (%)
23.59%
Price
08.01.26
€36.20
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 23.59%. This prediction currently runs until 30.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | 9.036% | 9.036% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat